NEW YORK (Reuters Health) Feb 28 – Many women purchase over-the-counter antifungal drugs based on a misperception that they have vulvovaginal candidiasis, researchers report in the March issue of Obstetrics and Gynecology.
"The FDA has allowed the use of over-the-counter antifungal drugs for treatment of self-diagnosed vulvovaginal candidiasis, although our study found the FDA's proper use stipulations ineffective," the authors write.
Dr. Daron G. Ferris, from the Medical College of Georgia, Augusta, and colleagues collected data on 95 symptomatic women who had purchased over-the-counter medications for treating vulvovaginal candidiasis.
Among these women, 32 had correctly diagnosed vulvovaginal candidiasis. However, 18 women had bacterial vaginosis, 19 had mixed vaginitis, 13 were normal, 10 women had other diagnoses, and 2 women had trichomonas vaginitis, the researchers found.
Dr. Ferris's group notes that women read the package label were not more …
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!